title: Is accuracy of serum free light chain measurement achievable?
abstract: The serum free light chain (FLC) assay has proven to be an important complementary test in the management of patients with monoclonal gammopathies. The serum FLC assay has value for patients with plasma cell disorders in the context of screening and diagnosis, prognostic stratification, and quantitative monitoring. Nonetheless, serum FLC measurements have analytical limitations which give rise to differences in FLC reporting depending on which FLC assay and analytical platform is used. As the FLC measurements are incorporated in the International Myeloma Working Group guidelines for the evaluation and management of plasma cell dyscrasias, this may directly affect clinical decisions. As new certified methods for serum FLC assays emerge, the need to harmonise patient FLC results becomes increasingly important. In this opinion paper we provide an overview of the current lack of accuracy and harmonisation in serum FLC measurements. The clinical consequence of non-harmonized FLC measurements is that an individual patient may or may not meet certain diagnostic, prognostic, or response criteria, depending on which FLC assay and platform is used. We further discuss whether standardisation of serum FLC measurements is feasible and provide an overview of the steps needed to be taken towards harmonisation of FLC measurements.
authors.forename: Joannes F M
authors.initials: JF
authors.lastname: Jacobs
authors.forename: Jillian R
authors.initials: JR
authors.lastname: Tate
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Merlini
mesh_terms: D001797:Blood Protein Electrophoresis / Q000379:methods; D000068598:Data Accuracy; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007147:Immunoglobulin Light Chains / Q000097:blood*; D009101:Multiple Myeloma / Q000175:diagnosis / Q000276:immunology
chemical_list: D007147:Immunoglobulin Light Chains